Basics Adaptive Biotechnologies Corporation IPO Date: June 24, 2019 Sector: Healthcare Industry: Biotech Market Cap: $1.36B Activated in VL: True Average Daily Range Avg Daily Range: $0.63 | 3.34% Avg Daily Range (30 D): $0.22 | 2.56% Avg Daily Range (90 D): $0.27 | 3.40% Institutional Daily Volume Avg Daily Volume: 1.02M Avg Daily Volume (30 D): 1.91M Avg Daily Volume (90 D): 1.76M Trade Size Avg Trade Size (Sh.): 94 Avg Trade Size (Sh.) (30 D): 82 Avg Trade Size (Sh.) (90 D): 87 Institutional Trades Total Inst.Trades: 2,564 Avg Inst. Trade: $1.85M Avg Inst. Trade (30 D): $1.81M Avg Inst. Trade (90 D): $1.65M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.26M Avg Closing Trade (30 D): $2.29M Avg Closing Trade (90 D): $1.96M Avg Closing Volume: 132.96K         News May 30, 2025 @ 11:30 AM Adaptive Biotechnologies Highlights New Data at 20... Source: Adaptive Biotechnologies Corporation Apr 8, 2025 @ 8:48 AM Minimal Residual Disease Testing Market Forecast R... Source: Researchandmarkets.Com Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire Dec 7, 2024 @ 11:30 PM Adaptive Biotechnologies Announces New Data at the... Source: Adaptive Biotechnologies Corporation Aug 15, 2024 @ 2:58 PM Laboratory-Developed Tests (LDTs) World Market For... Source: Researchandmarkets.Com Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.2 $-.22 Diluted EPS $-.2 $-.22 Revenue $ $ 52.44M $ 46.44M Gross Profit $ $ 35.46M $ 29.77M Net Income / Loss $ $ -29.83M $ -32.1M Operating Income / Loss $ $ -29.6M $ -32.63M Cost of Revenue $ $ 16.98M $ 16.67M Net Cash Flow $ $ 2.54M $ -21.74M PE Ratio